A double-blind comparative study of Chinese herbal medicine Jinlianqingre Effervescent Tablets in combination with conventional therapy for the treatment of uncomplicated hand, foot, and mouth disease

He, Liyun; Zhang, G.-L.; Yan, Shuping; Liu, Y.; Zhao, Changsong; Wang, X.-L.; Mi, Yuqiang; Liu, Y.-M.; Li, C.-P.; Kou, Yan; Li, Y.; Ke, Chang Wen; Meng, Xianli; Sun, Xiu-Rong; Zhao, Tengda; Li, J.; Wang, Y.-Y.; Liu, B.-Y.

doi:10.1007/s10096-014-2085-z

Cited by 6 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The infection is usually self-limiting and mild. However, some patients rapidly develop neurological and systemic complications that can be fatal [2]. HFMD is caused by various enteroviruses (EV), most commonly enterovirus 71 (EV-A71) or coxsackie virus A16 (CV-A16) [3–5].…”

Section: Introductionmentioning

confidence: 99%

Hand, Foot, and Mouth Disease in Hunan Province, China, 2009-2014: Epidemiology and Death Risk Factors

Luo

Gao

et al. 2016

PLoS ONE

View full text Add to dashboard Cite

Hand, foot, and mouth disease (HFMD) is an arising public health problem in Asia, including China. Epidemiological data is necessary to enable judicious public health responses and interventions. We analyzed the epidemiological and laboratory data of 759,301 HFMD cases reported to the Hunan Provincial Center for Disease Control and Prevention from 1 January 2009 to 31 December 2014. Univariate and multivariable conditional logistic regression analyses were used to identify risk factors of fatality in HFMD. The incidence of HFMD was highest among children aged 1–3 years, compared with other age groups. Of the total HFMD cases, 7,222 (0.95%) were considered severe and 338 (0.04%) were fatal. Enterovirus-A71 was the major cause of severe and fatal cases (65.75% and 88.78%, respectively). For severe cases, the median time from symptom onset to diagnosis was 0.5 days (interquartile range [IQR] 0–1.5 days); the median time from diagnosis to severe illness was 2 days (IQR 1–3 days). For fatal cases, the median time from symptom onset to diagnosis was 0.5 days (IQR 0–1.5 days); the median time from diagnosis to death was 1.5 days (IQR 0.5–2.5 days). In multivariable analysis, the abuse of antibiotic, glucocorticoid and pyrazolone in village clinics at basic medical institutions were identified as independent risk factors for HFMD fatal cases. In conclusion, our results suggest that the future direction to control and respond to HFMD is intensive surveillance of enterovirus-A71 and improving the ability to diagnose disease and treat patients, especially in basic medical institutions.

show abstract

Section: Introductionmentioning

confidence: 99%